BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND ERBB3, c-erbB3, 2065, P21860, p180-ErbB3, c-erbB-3, ErbB-3, MDA-BF-1, HER3, p85-sErbB3, MGC88033, p45-sErbB3, ENSG00000065361, erbB3-S AND Diagnosis
36 results:

  • 1. Stellate Ganglion Destruction With Alcohol Versus Thermal Ablation for Chronic Post-Mastectomy Pain: A Randomized Trial.
    Thabet TS; Khedr SA
    Pain Physician; 2024 Feb; 27(2):E231-E238. PubMed ID: 38324788
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Phenotype analysis of families with TP53 germline variants at the Center for Familial breast and Ovarian cancer, Cologne.
    Kast K; Rhiem K; Larsen M; Wappenschmidt B; Schmutzler R
    Cancer Med; 2024 Feb; 13(3):e6920. PubMed ID: 38230850
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinico-Pathological and Prognostic Significance of a Combination of Tumor Biomarkers in Iranian Patients With breast cancer.
    Hassanzadeh Makoui M; Mobini M; Fekri S; Geranpayeh L; Moradi Tabriz H; Madjd Z; Kalantari E; Hosseini M; Hosseini M; Golsaz-Shirazi F; Jeddi-Tehrani M; Zarnani AH; Amiri MM; Shokri F
    Clin Breast Cancer; 2024 Jan; 24(1):e9-e19.e9. PubMed ID: 37863762
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Axillary ultrasound for predicting response to neoadjuvant treatment in breast cancer patients-a single institution experience.
    Pislar N; Gasljevic G; Music MM; Borstnar S; Zgajnar J; Perhavec A
    World J Surg Oncol; 2023 Sep; 21(1):292. PubMed ID: 37715188
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. High neuroticism is associated with common late adverse effects in a nationwide sample of long-term breast cancer survivors.
    Dahl AA; Smedsland SK; Vandraas KF; Bøhn SK; Falk RS; Kiserud CE; Reinertsen KV
    Breast Cancer Res Treat; 2023 Nov; 202(1):97-104. PubMed ID: 37528264
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Sexual health in long-term breast cancer survivors: a comparison with female population controls from the HUNT study.
    Smedsland SK; Vandraas KF; Falk RS; Horn J; Reidunsdatter RJ; Kiserud CE; Dahl AA; Brekke M; Reinertsen KV
    Breast Cancer Res Treat; 2023 Oct; 201(3):479-488. PubMed ID: 37490170
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Frequent Overexpression of her3 in Brain Metastases from breast and Lung cancer.
    Tomasich E; Steindl A; Paiato C; Hatziioannou T; Kleinberger M; Berchtold L; Puhr R; Hainfellner JA; Müllauer L; Widhalm G; Eckert F; Bartsch R; Heller G; Preusser M; Berghoff AS
    Clin Cancer Res; 2023 Aug; 29(16):3225-3236. PubMed ID: 37036472
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Knowledge regarding breast cancer among Congolese women in Kinshasa, Democratic Republic of the Congo.
    Sulu SMM; Mukuku O; Sulu AMS; Massamba BL; Mashinda DK; Tshimpi AW
    Cancer Rep (Hoboken); 2023 Mar; 6(3):e1758. PubMed ID: 36404296
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Health literacy among long-term survivors of breast cancer; exploring associated factors in a nationwide sample.
    Vandraas KF; Reinertsen KV; Kiserud CE; Bøhn SK; Lie HC
    Support Care Cancer; 2022 Sep; 30(9):7587-7596. PubMed ID: 35674792
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Recent Advances in Epidermal Growth Factor Receptor Inhibitors (EGFRIs) and their Role in the Treatment of cancer: A Review.
    Unnisa A; Chettupalli AK; Hussain T; Kamal MA
    Anticancer Agents Med Chem; 2022; 22(20):3370-3381. PubMed ID: 35400324
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Work status changes and associated factors in a nationwide sample of Norwegian long-term breast cancer survivors.
    Bøhn SH; Vandraas KF; Kiserud CE; Dahl AA; Thorsen L; Ewertz M; Lie HC; Falk R; Reinertsen KV
    J Cancer Surviv; 2024 Apr; 18(2):375-384. PubMed ID: 35314959
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. diagnosis and Treatment of ERBB2-Positive Metastatic Colorectal cancer: A Review.
    Strickler JH; Yoshino T; Graham RP; Siena S; Bekaii-Saab T
    JAMA Oncol; 2022 May; 8(5):760-769. PubMed ID: 35238866
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Sexual activity and functioning in long-term breast cancer survivors; exploring associated factors in a nationwide survey.
    Smedsland SK; Vandraas KF; Bøhn SK; Dahl AA; Kiserud CE; Brekke M; Falk RS; Reinertsen KV
    Breast Cancer Res Treat; 2022 May; 193(1):139-149. PubMed ID: 35226237
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Introduction of hsa-miR-512-3p as a new regulator of HER2 signaling pathway in breast cancer.
    Mohamadzade Z; Mahjoubi F; Soltani BM
    Breast Cancer Res Treat; 2021 Jan; 185(1):95-106. PubMed ID: 32974790
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Genomic Profiling Aids Classification of Diagnostically Challenging Uterine Mesenchymal Tumors With Myomelanocytic Differentiation.
    Selenica P; Conlon N; Gonzalez C; Frosina D; Jungbluth AA; Beets-Tan RGH; Rao MK; Zhang Y; Benayed R; Ladanyi M; Solit DB; Chiang S; Hyman DM; Hensley ML; Soslow RA; Weigelt B; Murali R
    Am J Surg Pathol; 2021 Jan; 45(1):77-92. PubMed ID: 32889887
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Integrated molecular profiling of young and elderly patients with triple-negative breast cancer indicates different biological bases and clinical management strategies.
    Ma D; Jiang YZ; Xiao Y; Xie MD; Zhao S; Jin X; Xu XE; Shao ZM
    Cancer; 2020 Jul; 126(14):3209-3218. PubMed ID: 32383785
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Precision prophylaxis: Identifying the optimal timing for risk-reducing salpingo-oophorectomy based on type of BRCA1 and BRCA2 cluster region mutations.
    Solsky I; Chen J; Rebbeck TR
    Gynecol Oncol; 2020 Feb; 156(2):363-376. PubMed ID: 31918993
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Targeted deep sequencing revealed variants in cell-free DNA of hormone receptor-positive metastatic breast cancer patients.
    Keup C; Benyaa K; Hauch S; Sprenger-Haussels M; Tewes M; Mach P; Bittner AK; Kimmig R; Hahn P; Kasimir-Bauer S
    Cell Mol Life Sci; 2020 Feb; 77(3):497-509. PubMed ID: 31254045
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Emerging ways to treat breast cancer: will promises be met?
    Samadi P; Saki S; Dermani FK; Pourjafar M; Saidijam M
    Cell Oncol (Dordr); 2018 Dec; 41(6):605-621. PubMed ID: 30259416
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Clinical manifestations and STK11 germline mutations in Taiwanese patients with Peutz-Jeghers syndrome.
    Chiang JM; Chen TC
    Asian J Surg; 2018 Sep; 41(5):480-485. PubMed ID: 28869103
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.